These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 2413564
1. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins. MacGregor IR, Dawes J, Pepper DS, Prowse CV, Stocks J. Thromb Haemost; 1985 Jun 24; 53(3):411-4. PubMed ID: 2413564 [Abstract] [Full Text] [Related]
2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP. Thromb Haemost; 1982 Apr 30; 47(2):109-13. PubMed ID: 6179183 [Abstract] [Full Text] [Related]
3. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation. Fischer AM, Barrowcliffe TW, Thomas DP. Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182 [Abstract] [Full Text] [Related]
4. Metabolism of sodium pentosan polysulphate in man--catabolism of iodinated derivatives. MacGregor IR, Dawes J, Paton L, Pepper DS, Prowse CV, Smith M. Thromb Haemost; 1984 Jul 29; 51(3):321-5. PubMed ID: 6208629 [Abstract] [Full Text] [Related]
5. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL). Barrowcliffe TW, Gray E, Merton RE, Dawes J, Jennings CA, Hubbard AR, Thomas DP. Thromb Haemost; 1986 Oct 21; 56(2):202-6. PubMed ID: 2433786 [Abstract] [Full Text] [Related]
6. A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse. Orme CE, Harris RC. Acta Physiol Scand; 1997 Feb 21; 159(2):179-85. PubMed ID: 9055947 [Abstract] [Full Text] [Related]
7. The effect of pentosan polysulphate (SP54) on the human fibrinolytic system. Gaffney PJ, Marsh NA. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Feb 21; 113(1-2):262-71. PubMed ID: 2427409 [Abstract] [Full Text] [Related]
8. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Dawes J, Prowse CV, Pepper DS. Thromb Res; 1986 Dec 01; 44(5):683-93. PubMed ID: 2433788 [Abstract] [Full Text] [Related]
9. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation. Dol F, Sié P, Dupouy D, Boneu B. Thromb Haemost; 1986 Dec 15; 56(3):295-8. PubMed ID: 2436330 [Abstract] [Full Text] [Related]
10. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study. Marsh NA, Peyser PM, Creighton LJ, Mahmoud M, Gaffney PJ. Thromb Haemost; 1985 Dec 17; 54(4):833-7. PubMed ID: 2418527 [Abstract] [Full Text] [Related]
11. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. An experimental animal study. Marsh NA, Gaffney PJ. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Dec 17; 113(1-2):255-61. PubMed ID: 2427408 [Abstract] [Full Text] [Related]
12. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers. Sié P, Albarede JL, Robert M, Bouloux C, Lansen J, Chigot C, Correll S, Thouvenot JP, Boneu B. Thromb Haemost; 1986 Feb 28; 55(1):86-9. PubMed ID: 2422778 [Abstract] [Full Text] [Related]
13. The APTT response of pregnant plasma to unfractionated heparin. Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS. Thromb Haemost; 2002 Jan 28; 87(1):92-7. PubMed ID: 11848463 [Abstract] [Full Text] [Related]
14. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54). Scully MF, Kakkar VV. Thromb Res; 1984 Oct 15; 36(2):187-94. PubMed ID: 6209821 [Abstract] [Full Text] [Related]
15. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man]. Caporiccio B, Braun M, Vignaud M, Chalet M, Teste J, Codomier L, Catayée G. C R Seances Soc Biol Fil; 1983 Oct 15; 177(4):412-20. PubMed ID: 6202380 [Abstract] [Full Text] [Related]
16. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy. Forestier F, Fischer AM, Daffos F, Beguin S, Diner H. Thromb Haemost; 1986 Dec 15; 56(3):247-9. PubMed ID: 2436327 [Abstract] [Full Text] [Related]
17. [Clinical experience with heparinoid sodium pentosan polysulfate (SP54) in the treatment of cerebral ischemia]. Szirmai I, Fendler K, Kollár L, Romhányi M. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Dec 15; 113(1-2):278-88. PubMed ID: 2427411 [Abstract] [Full Text] [Related]
18. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). Persson E. Acta Med Scand Suppl; 1988 Dec 15; 724():1-56. PubMed ID: 2843005 [Abstract] [Full Text] [Related]
19. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin. Vinazzer H, Haas S, Stemberger A. Thromb Res; 1980 Oct 01; 20(1):57-68. PubMed ID: 6163222 [No Abstract] [Full Text] [Related]
20. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects. Harenberg J, Stehle G, Dempfle CE, von Hodenberg E, Heene DL. Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Oct 01; 116(6):967-80. PubMed ID: 2483715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]